Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Dr. Martens PLC (DOCS)

London
Currency in GBP
Disclaimer
72.15
+0.80(+1.12%)
Real-time Data

DOCS Price Commentary

Can not see an upside for this share for the time being and the share price since launch has been sliding downhill all the way. I wouldn't be suprised to see it fall between 80p-90p before a recovery. Fair amount of negative sentiment on some of it's product line. Perhaps the shares over valued from the start?
Share buybacks and activist fund manager Sparta Capital accumulated stock worth tens of millions of pounds maybe put a floor on it.
IPO = It's Probably Overpriced.
luckily still just watching 221p
Still sidelined @194
I'm in now speculative 155p
Even 155 looks too much for this stock… let it slip to 110 before you can average your buy… i also bought at 146 yesterday
Even 100 is too expensive for money losing company with very high P/E ratio. Don't buy if you do not want lose your money
still watching now 330p early 2022
luckily only watching 280p now after trading update. looked good to me though...
Share price bit like the shoes-overpriced sub 375p value level (413 today)
borderline FTSE100 material 483p
Watching this for weeks in now 462p
I only see value at 420p
why has this stock fallen much like many other recent IPOs where small traders lose money much like KANABO...
The shares were incorrectly valued (over valued) at the time of the IPO. This often is the case which benefits the company and not the shareholder.
442p
480p
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.